Neuroimaging Correlates of Depression—Implications to Clinical Practice
The growth of the literature about neuroimaging of major depressive disorder (MDD) over the last several decades has contributed to the progress in recognizing precise brain areas, networks, and neurotransmitter processes related to depression. However, there are still doubts about the etiology and...
Main Authors: | Lígia Castanheira, Carlos Silva, Elie Cheniaux, Diogo Telles-Correia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00703/full |
Similar Items
-
Neuroreceptor imaging in depression
by: Jonathan B. Savitz, et al.
Published: (2013-04-01) -
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
by: Erica M. Richards, et al.
Published: (2018-07-01) -
Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
by: Seung-Gul Kang, et al.
Published: (2020-03-01) -
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
by: Kristin Köhler-Forsberg, et al.
Published: (2020-07-01) -
Neuroimaging in epilepsy
by: Roy Trishit, et al.
Published: (2011-01-01)